Short Wave - Once A Satirical Conspiracy, Bird Drones Could Soon Be A Reality

Millions of people in the U.S. are bird watchers. But a couple of years ago a satirical conspiracy theory gained popularity because of an absurd claim: That those birds were also watching people.

Now, rather than being the stuff of internet memes, some engineers are, in fact, trying to reverse engineer how birds fly to eventually take what they learn to create more efficient bird-like drones.

Today on the show, host Regina G. Barber talks to reporter Anil Oza about how scientists are using real birds to make fake ones.

Want to learn more about innovations in science? Email us at shortwave@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Pod Save America - PSA Presents: The 2023 Pundies

Welcome to the only award that really matters: The Pundies. Jon, Jon, Tommy, and Dan are joined by Halle Kiefer to decide the worst takes of 2023 (including their own). Then they react to their 2023 new year’s resolutions and make some new ones for 2024. Happy Holidays!

 

For a closed-captioned version of this episode, click here. For a transcript of this episode, please email transcripts@crooked.com and include the name of the podcast.

 

This Machine Kills - 305. What’s the Value of Data? (ft. Salomé Viljoen)

Returning champ Salomé Viljoen joins us once again to discuss her latest work analyzing the relationship between social data and value creation. We get into the conversion problem of turning data into money, which requires us to expand our view of data and break from the bonds of pure exchange value to also think about social data’s “prediction value.” We also talk about why our current legal regimes of data governance are unequipped and ineffective at governing the political economy of social data—and the change that is needed. ••• Follow Salomé: https://twitter.com/salome_viljoen_ ••• Valuing Social Data https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4513235 Subscribe to hear more analysis and commentary in our premium episodes every week! https://www.patreon.com/thismachinekills Hosted by Jathan Sadowski (www.twitter.com/jathansadowski) and Edward Ongweso Jr. (www.twitter.com/bigblackjacobin). Production / Music by Jereme Brown (www.twitter.com/braunestahl)

It Could Happen Here - Amos Time in Detention Part 2

Amos shares the story of his time in indoor detention and his journey back to his family. 

You can donate to Amos via Venmo at https://venmo.com/u/fueguitosdelanoche, please indicate "For Amos" in your notes.

See omnystudio.com/listener for privacy information.

array(3) { [0]=> string(150) "https://www.omnycontent.com/d/programs/e73c998e-6e60-432f-8610-ae210140c5b1/78d30acb-8463-4c40-a5ae-ae2d0145c9ff/image.jpg?t=1749835422&size=Large" [1]=> string(10) "image/jpeg" [2]=> int(0) }

Consider This from NPR - Oprah’s Done with the Shame. The New Weight Loss Drugs.

Americans are increasingly using drugs like Ozempic, Wegovy and Mounjaro to lose weight. And they got a big endorsement last week when Oprah Winfrey announced that she, too was using weight loss drugs.

And it's not just Oprah, the decades-old weight management company Weight Watchers is also embracing the drugs, integrating them into the business model.

NPR's Juana Summers speaks with Weight Watchers CEO Sima Sistani about the company's decision, and talks to NPR consumer health correspondent Yuki Noguchi about what is known and unknown about these drugs.

Email us at considerthis@npr.org


Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Consider This from NPR - Oprah’s Done with the Shame. The New Weight Loss Drugs.

Americans are increasingly using drugs like Ozempic, Wegovy and Mounjaro to lose weight. And they got a big endorsement last week when Oprah Winfrey announced that she, too was using weight loss drugs.

And it's not just Oprah, the decades-old weight management company Weight Watchers is also embracing the drugs, integrating them into the business model.

NPR's Juana Summers speaks with Weight Watchers CEO Sima Sistani about the company's decision, and talks to NPR consumer health correspondent Yuki Noguchi about what is known and unknown about these drugs.

Email us at considerthis@npr.org


Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Consider This from NPR - Oprah’s Done with the Shame. The New Weight Loss Drugs.

Americans are increasingly using drugs like Ozempic, Wegovy and Mounjaro to lose weight. And they got a big endorsement last week when Oprah Winfrey announced that she, too was using weight loss drugs.

And it's not just Oprah, the decades-old weight management company Weight Watchers is also embracing the drugs, integrating them into the business model.

NPR's Juana Summers speaks with Weight Watchers CEO Sima Sistani about the company's decision, and talks to NPR consumer health correspondent Yuki Noguchi about what is known and unknown about these drugs.

Email us at considerthis@npr.org


Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy